Abstract
Our previous studies have characterized Dexamethasone (Dex)-induced apoptotic signaling pathways in multiple myeloma (MM) cells; however, related transcriptional events are not fully defined. In the present study, gene expression profiles of Dex-treated MM cells were determined using oligonucleotide arrays. Dex triggers early transient induction of many genes involved in cell defense/repair-machinery. This is followed by induction of genes known to mediate cell death and repression of growth/survival-related genes. The molecular and genetic alterations associated with Dex resistance in MM cells are also unknown. We compared the gene expression profiles of Dex-sensitive and Dex-resistant MM cells and identified a number of genes which may confer Dex-resistance. Finally, gene profiling of freshly isolated MM patient cells validates our in vitro MM cell line data, confirming an in vivo relevance of these studies. Collectively, these findings provide insights into the basic mechanisms of Dex activity against MM, as well as mechanisms of Dex-resistance in MM cells. These studies may therefore allow improved therapeutic uses of Dex, based upon targeting genes that regulate MM cell growth and survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alexanian R, Dimopoulos MA, Delasalle K, Barlogie B . 1992 Blood 80: 887–890
Anderson KC, Jones RM, Morimoto C, Leavitt P, Barut BA . 1989 Blood 73: 1915–1924
Anderson KC, Lust JL . 1999 Semin. Hematol. 36: 14–20
Anderson KC . 2001 Semin. Hematol. 38: 286–294
Barut B, Chauhan D, Uchiyama H, Anderson KC . 1993 J. Clin. Invest. 92: 2346–2352
Bataille R, Barlogie B, Lu ZY, Rossi JF, Lavabre-Bertrand T, Beck T, Wijdenes J, Brochier J, Klein B . 1995 Blood 86: 685–691
Barkett M, Gilmore TD . 1999 Oncogene 18: 6910–6924
Bours V, Bentires-Alj M, Hellin AC, Viatour P, Robe P, Delhalle S, Benoit V, Merville MP . 2000 Biochem. Pharmacol. 60: 1085–1089
Bajpai UD, Zhang K, Teutsch M, Sen R, Wortis HH . 2000 J. Exp. Med. 191: 1735–1744
Chaudhry A, Oberg K, Gobl A, Heldin CH, Funa K . 1994 Antican. Res. 14: 2085–2091
Chauhan D, Anderson KC . 2001 Apoptosis 6: 47–55
Chauhan D, Hideshima T, Pandey P, Treon SP, Teoh G, Rosen S, Krett N, Husson H, Avraham S, Kharbanda S, Anderson KC . 1999 Oncogene 18: 6733–6740
Chauhan D, Kharbanda SM, Rubin E, Barut BA, Mohrbacher A, Kufe DW, Anderson KC . 1993 Blood 81: 1540–1548
Chauhan D, Kharbanda SM, Uchiyama H, Sukhatme VP, Kufe DW, Anderson KC . 1994 Can. Res. 54: 2234–2239
Chauhan D, Pandey P, Ogata A, Teoh G, Krett N, Halgren R, Rosen S, Kufe D, Kharbanda S, Anderson KC . 1997a J. Biol. Chem. 272: 29995–29997
Chauhan D, Pandey P, Ogata A, Teoh G, Treon S, Urashima M, Kharbanda S, Anderson KC . 1997b Oncogene 15: 837–843
Chauhan D, Pandey P, Hideshima TH, Treon S, Raje N, Davies FE, Shima Y, Tai YT, Rosen S, Avraham S, Kharbanda S, Anderson KC . 2000 J. Biol. Chem. 275: 27845–27850
Chauhan D, Uchiyama H, Akbarali Y, Urashima M, Yamamoto K, Libermann TA, Anderson KC . 1996 Blood 87: 1104–1112
Combadiere C, Salzwedel K, Smith ED, Tiffany HL, Berger EA, Murphy PM . 1998 J. Biol. Chem. 273: 23799–23804
Der SD, Zhou A, Williams BR, Silverman RH . 1998 Proc. Natl. Acad. Sci. USA 95: 15623–15628
Desai SD, Mao Y, Sun M, Li TK, Wu J, Liu LF . 2000 Ann. NY Acad. Sci. 922: 306–308
Dell'Angelica EC, Ohno H, Ooi CE, Rabinovich E, Roche KW, Bonifacino JS . 1997 EMBO J. 16: 917–928
Eisen MB, Spellman PT, Brown PO, Botstein D . 1998 Proc. Natl. Acad. Sci. USA 95: 14863–14868
Feinman R, Koury J, Thames M, Barlogie B, Epstein J, Siegel DS . 1999 Blood 93: 3044–3052
Fischer CP, Bode BP, Takahashi K, Tanabe KK, Souba WW . 1996 Ann. Surg. 223: 610–618 Discussion 618–619
Fraticelli P, Sironi M, Bianchi G, D'Ambrosio D, Albanesi C, Stoppacciaro A, Chieppa M, Allavena P, Ruco L, Girolomoni G, Sinigaglia F, Vecchi A, Mantovani A . 2001 J. Clin. Invest. 107: 1173–1181
Goldman-Leikin RE, Salwen HR, Herst CV, Variakojis D, Bian ML, Le Beau MM, Selvanayagan P, Marder R, Anderson R, Weitzman S . 1989 J. Lab. Clin. Med. 113: 335–345
Garrido C, Ottavi P, Fromentin A, Hammann A, Arrigo AP, Chauffert B, Mehlen P . 1997 Cancer Res. 57: 2661–2667
Garrido C, Fromentin A, Bonnotte B, Favre N, Moutet M, Arrigo AP, Mehlen P, Solary E . 1998 Cancer Res. 58: 5495–5499
Golub TR, Slonim D, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES . 1999 Science 286: 531–537
Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, Solary E . 1999 FASEB J. 13: 2061–2070
Hardin J, Macleod S, Grigorieva I, Chang R, Barlogie B, Xiao X, Epstein J . 1994 Blood 84: 3063–3070
Hideshima T, Chauhan D, Schlossman R, Richardson P, Anderson KC . 2001a Oncogene 20: 4519–4527
Hideshima T, Nakamura N, Chauhan D, Anderson KC . 2001b Oncogene 20: 5991–6000
Hideshima T, Richardson P, Chauhan D, Palaomabella V, Elliott PJ, Adams J, Anderson KC . 2001c Con. Res. 61: 3071–3076
Juge-Morineau N, Francois S, Puthier D, Godard A, Bataille R, Amiot M . 1995 Br. J. Haematol. 90: 707–710
Jaattela M . 1999 Ann. Med. 31: 261–271
Jaattela M, Wissing D, Kokholm K, Kallunki T, Egeblad M . 1998 EMBO J. 17: 6124–6134
Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW . 2001 J. Biol. Chem. 276: 11199–11203
Karin M, Ben-Neriah Y . 2000 Annu. Rev. Immunol. 18: 621–663
Klein B, Zhang XG, Jourden M, Content M, Houssiau F, Aarden L, Piechaczyk M, Bataille R . 1989 Blood 73: 517–526
Kohler HB, Huchzermeyer B, Martin M, De Bruin A, Meier B, Nolte I . 2001 Vet. Dermatol. 12: 129–137
Krett NL, Zell JL, Halgren RG, Pillay S, Traynor AE, Rosen ST . 1997 Clin. Can. Res. 3: 1781–1787
Kudoh K, Manasi R, Ravatin R, Elkahloun AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS, Chin KV . 2001 Can. Res. 60: 4161–4166
Lichtenstein A, Tu Y, Fady C, Vescio R, Berenson J . 1995 Cell Immunol. 162: 248–255
Levy Y, Labaume S, Colombel M, Brouet JC . 1996 Clin. Exp. Immunol. 104: 167–172
Li C, Wong WH . 2001 Proc. Natl. Acad. Sci. USA 98: 31–36
Matsuda S, Rouault J, Magaud J, Berthet C . 2001 FEBS Lett. 497: 67–72
Moalli PA, Pillay S, Weiner D, Leikin R, Rosen ST . 1992 Blood 79: 213–222
Moalli PA, Pillay S, Krett NL, Rosen ST . 1993 Cancer Res. 53: 3877–3879
Mehlen P, Schulze-Osthoff K, Arrigo AP . 1996 J. Biol. Chem. 271: 16510–16514
Mori S, Murakami-Mori K, Bonavida B . 1998 Antican. Res. 18: 4403–4408
Ogata A, Chauhan D, Teoh G, Treon SP, Urashima M, Schlossman RL, Anderson KC . 1997 J. Immunology 159: 2212–2221
Pahl HL . 1999 Oncogene 18: 6853–6866
Petro JB, Khan WN . 2001 J. Biol. Chem. 276: 1715–1719
Podar K, Tai TY, Davies FE, Lentzsch S, Sattler M, Hideshima T, Lin BK, Gupta D, Chauhan D, Mitsiades C, Raje N, Richardson P, Anderson K . 2001 Blood 98: 428–435
Rowland TL, McHugh SM, Deighton J, Ewan PW, Dearman RJ, Kimber I . 2001 Int. Immunopharmacol. 1: 49–61
Salmon SE . 1984 Cancer Treat. Rep. 68: 117–125
Smith MR, Xie T, Joshi I, Schilder RJ . 1998 Br. J. Haematol. 102: 1090–1097
Spataro V, Norbury C, Harris AL . 1998 Br. J. Cancer 77: 448–455
Tassone P, Forciniti S, Galea E, Savino R, Turco MC, Iacopino P, Tagliaferri P, Morrone G, Ciliberto G, Venuta S . 2000 Cell Death Differ. 7: 327–328
Uchiyama H, Barut BA, Mohrbacher AF, Chauhan D, Anderson KC . 1993 Blood 82: 3712–3720
Urashima M, Ogata A, Chauhan D, Hatziyanni M, Vidriales MB, Dedera DA, Schlossman RL, Anderson KC . 1996 Blood 87: 1928–1938
Volin MV, Woods JM, Amin MA, Connors MA, Harlow LA, Koch AE . 2001 Am. J. Pathol. 159: 1521–1530
Wu C, Ghosh S . 1999 J. Biol. Chem. 274: 29591–29594
Yang HS, Jansen AP, Nair R, Shibahara K, Verma AK, Cmarik JL, Colburn NH . 2001 Oncogene 20: 669–676
Zimmermann J, Erdmann D, Lalande I, Grossenbacher R, Noorani M, Furst P . 2000 Oncogene 19: 2913–2920
Acknowledgements
This investigation was supported by NIH CA 78373 awarded by the National Cancer Institute, Multiple Myeloma Research Foundation Senior Research Scientist Awards (D Chauhan, T Hideshima), and a Doris Duke Distinguished Clinical Research Scientist Award (KC Anderson).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chauhan, D., Auclair, D., Robinson, E. et al. Identification of genes regulated by Dexamethasone in multiple myeloma cells using oligonucleotide arrays. Oncogene 21, 1346–1358 (2002). https://doi.org/10.1038/sj.onc.1205205
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205205
Keywords
This article is cited by
-
RNF6 promotes myeloma cell proliferation and survival by inducing glucocorticoid receptor polyubiquitination
Acta Pharmacologica Sinica (2020)
-
Glucocorticoids in multiple myeloma: past, present, and future
Annals of Hematology (2019)
-
Protective effects of cytokine combinations against the apoptotic activity of glucocorticoids on CD34+ hematopoietic stem/progenitor cells
Cytotechnology (2019)
-
RETRACTED ARTICLE: The effects of dexamethasone on the proliferation and apoptosis of human ovarian cancer cells induced by paclitaxel
Journal of Ovarian Research (2014)
-
A novel Bruton’s tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity
Leukemia (2014)